Trial Profile
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Parallel Study to Assess the Effects of Avanafil (STENDRA) on Multiple Parameters of Vision, Including, But Not Limited to Visual Acuity, Intraocular Pressure, Pupillometry, and Color Vision Discrimination, in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2021
Price :
$35
*
At a glance
- Drugs Avanafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacodynamics
- Sponsors VIVUS
- 19 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2014 New trial record